Amy Chadburn Selected Research

Amy Chadburn Research Topics

Disease

28	Lymphoma (Lymphomas) 03/2024 - 10/2002
28	Neoplasms (Cancer) 06/2023 - 10/2002
13	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 08/2004
11	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 08/2003
10	B-Cell Lymphoma (Lymphoma, B Cell) 06/2023 - 10/2002
7	Hodgkin Disease (Hodgkin's Disease) 08/2023 - 01/2007
7	COVID-19 01/2023 - 11/2020
7	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021 - 10/2002
5	Primary Effusion Lymphoma 01/2023 - 05/2008
5	Anemia 03/2017 - 04/2003
5	Acquired Immunodeficiency Syndrome (AIDS) 01/2016 - 09/2005
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2011 - 10/2002
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2023 - 03/2003
4	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2023 - 03/2008
4	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2023 - 10/2006
4	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 02/2007
4	Infections 11/2021 - 02/2004
3	beta-Thalassemia (Cooley's Anemia) 06/2007 - 03/2002
2	Hyperplasia 03/2024 - 10/2006
2	Carcinogenesis 06/2023 - 06/2008
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 08/2003
2	Thrombotic Microangiopathies 01/2022 - 01/2018
2	Cytokine Release Syndrome 12/2020 - 03/2017
2	Plasmablastic Lymphoma 10/2020 - 01/2016
2	Thrombocytopenia (Thrombopenia) 10/2020 - 03/2017
2	Paraproteinemias (Monoclonal Gammopathy) 03/2020 - 02/2013
2	Cytopenia 03/2020 - 03/2017
2	Inflammation (Inflammations) 01/2019 - 06/2008
2	Trisomy (Trisomies) 01/2018 - 08/2003
2	Castleman Disease (Castleman's Disease) 03/2017 - 02/2007
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 02/2017 - 03/2003
2	Leukemia 05/2012 - 02/2004
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2006 - 10/2002
1	Non-ST Elevated Myocardial Infarction 11/2023
1	Myocardial Infarction 11/2023
1	Virus Diseases (Viral Diseases) 06/2023
1	Coronavirus Infections 01/2023
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 03/2021
1	Critical Illness (Critically Ill) 01/2021

Drug/Important Bio-Agent (IBA)

9	Rituximab (Mabthera)FDA Link 01/2023 - 08/2005
7	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2023 - 09/2005
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2004
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2009
6	Vincristine (Oncovin)FDA LinkGeneric 10/2020 - 09/2005
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020 - 09/2005
6	Prednisone (Sone)FDA LinkGeneric 10/2020 - 09/2005
5	AntibodiesIBA 04/2021 - 02/2004
5	AntigensIBA 03/2021 - 11/2004
5	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 11/2004
4	Interleukin-6 (Interleukin 6)IBA 01/2023 - 03/2017
4	RNA (Ribonucleic Acid)IBA 11/2021 - 03/2005
4	Etoposide (VP 16)FDA LinkGeneric 10/2020 - 10/2009
4	MicroRNAs (MicroRNA)IBA 12/2010 - 03/2005
3	Neutralizing AntibodiesIBA 04/2021 - 11/2020
3	EnzymesIBA 11/2009 - 10/2002
3	Monoclonal AntibodiesIBA 08/2005 - 08/2003
3	epratuzumabIBA 08/2005 - 08/2003
2	ChromatinIBA 03/2024 - 02/2023
2	Brentuximab VedotinIBA 08/2023 - 05/2014
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 02/2004
2	Dasatinib (BMS 354825)FDA Link 01/2023 - 04/2020
2	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2022 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	ParaffinIBA 11/2021 - 01/2019
2	Formaldehyde (Formol)FDA Link 11/2021 - 01/2019
2	Messenger RNA (mRNA)IBA 10/2021 - 10/2002
2	IronIBA 01/2021 - 06/2007
2	Immunoglobulin M (IgM)IBA 01/2021 - 02/2013
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2021
2	Oncogene Proteins (Oncogene Protein)IBA 01/2017 - 02/2004
2	Nuclear Antigens (Extractable Nuclear Antigens)IBA 12/2008 - 02/2007
2	LigandsIBA 02/2007 - 03/2004
2	IodineIBA 02/2007 - 08/2005
2	beta-Globins (beta Globin)IBA 04/2003 - 03/2002
2	Hemoglobins (Hemoglobin)IBA 04/2003 - 03/2002
1	Nucleosomes (Nucleosome)IBA 03/2024
1	TroponinIBA 11/2023
1	trans-crotonin (CTN)IBA 11/2023
1	Vinblastine (Vinblastine Sulfate)FDA Link 08/2023
1	Dacarbazine (DIC)FDA LinkGeneric 08/2023
1	TESIBA 06/2023
1	DNA Transposable Elements (Element, IS)IBA 06/2023
1	carboxyl radical (COO-)IBA 06/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	COVID-19 VaccinesIBA 10/2021
1	CholesterolIBA 01/2021
1	Lipoproteins (Lipoprotein)IBA 01/2021
1	high density lipoprotein receptorsIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021

Therapy/Procedure

25	Therapeutics 01/2023 - 02/2004
7	Drug Therapy (Chemotherapy) 01/2023 - 08/2005
3	Immunotherapy 02/2023 - 09/2005
2	Stem Cell Transplantation 11/2023 - 06/2010
2	Breast Implants (Breast Implant) 02/2017 - 03/2003
2	Highly Active Antiretroviral Therapy (HAART) 01/2016 - 03/2008
2	Splenectomy 04/2008 - 07/2006
2	Radioimmunotherapy 02/2007 - 08/2005
2	Organ Transplantation 08/2006 - 03/2003
1	Art Therapy 08/2023